Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 3, 2009, Pages 725-733

  Salama, Joseph K ^a   Haddad, Robert I ^b   Kies, Merril S ^c   Busse, Paul M ^d   Dong, Lei ^c   Brizel, David M ^e   Eisbruch, Avraham ^f   Tishler, Roy B ^b   Trotti, Andy M ^g   Garden, Adam S ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e DUKE CANCER INSTITUTE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Head and neck cancer; Induction chemotherapy; Intensity modulated radiotherapy; Radiotherapy planning

Indexed keywords

CLINICAL PRACTICES; COMPLETE RESPONSE; CONCURRENT CHEMORADIOTHERAPY; HEAD-AND-NECK CANCER; HIGH QUALITY; INDUCTION CHEMOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; MANAGEMENT TEAM; MULTI-DISCIPLINARY APPROACH; NORMAL ANATOMY; RADIATION ONCOLOGISTS; RADIOTHERAPY PLANNING; RAPID RESPONSE; TARGET VOLUMES; TUMOR VOLUMES;

CHEMOTHERAPY; MANAGEMENT SCIENCE; PATIENT MONITORING; RADIOTHERAPY;

PLANNING;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HUMAN; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; NUTRITION ASSESSMENT; PHYSICAL EXAMINATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 70349556714     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.059     Document Type: Article

References (53)

1. American Cancer Society. Cancer facts and figures 2008 (2008), American Cancer Society, Atlanta, GA
2. Monnerat C., Faivre S., Temam S., et al. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 13 (2002) 995-1006
3. National Cancer Institute. Head and neck cancer: Questions and answers. Available from: http://www.cancer.gov/cancertopics/factsheet/Sites-Types/head-and-neck. Accessed September 15, 2008.
4. Fuller C.D., Wang S.J., Thomas Jr. C.R., et al. Conditional survival in head and neck squamous cell carcinoma: Results from the SEER dataset 1973-1998. Cancer 109 (2007) 1331-1343
5. Bachaud J.M., Cohen-Jonathan E., Alzieu C., et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
6. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
7. Bourhis, Amand C., Pignon J.P., and MACH-NC Collaborative Group. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. Proc Am Soc Clin Oncol 22 (2004) 488
8. Budach W., Hehr T., Budach V., et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6 (2006) 28
9. Pignon J.P., Bourhis J., Domenge C., et al., Meta-Analysis of Chemotherapy on Head and Neck Cancer (MACH-NC) Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
10. Salama J.K., Seiwert T.Y., and Vokes E.E. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 25 (2007) 4118-4126
11. Adelstein D.J., Saxton J.P., Rybicki L.A., et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution. J Clin Oncol 24 (2006) 1064-1071
12. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
13. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
14. Kies M.S., Haraf D.J., Rosen F., et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19 (2001) 1961-1969
15. Calais G., Pointreau Y., Alfonsi M., et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer: Preliminary results of GORTEC 2000-01 [Abstract 5506]. 2006 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 24 Suppl (2006) 5506
16. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
17. Vermorken J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
18. National Cancer Institute. FDA approval for docetaxel. Available from: http://www.cancer.gov/cancertopics/druginfo/fda-docetaxel#Anchor-Hea-39459. Accessed September 15, 2008.
19. Eisbruch A. Commentary: Induction chemotherapy for head and neck cancer: Hypothesis-based rather than evidence-based medicine. Oncologist 12 (2007) 975-977
20. Garden A.S. Is there still a role for induction chemotherapy for head and neck cancer?. J Clin Oncol 23 (2005) 1059-1060
21. Kies M.S. Induction chemotherapy for squamous cancer of the head and neck. Curr Oncol Rep 9 (2007) 129-133
22. U.S. National Institutes of Health. Docetaxel based chemotherapy plus or minus induction chemotherapy to decrease events in head and neck cancer (DeCIDE). ClinicalTrials.gov Web site. Available from: http://www.clinicaltrials.gov/ct/show/NCT00117572?order=1. Accessed September 15, 2008.
23. US National Institutes of Health. Combination chemotherapy and radiation therapy in treating patients with stage III or stage IV head and neck cancer. ClinicalTrials.gov Web Site. Available at: http://www.clinicaltrials.gov/ct/show/NCT00095875?order=2. Accessed September 15, 2008.
24. David M.B., and Eisbruch A. Delineating neck targets for intensity-modulated radiation therapy of head and neck cancer: What we learned from marginal recurrences?. Front Radiat Ther Oncol 40 (2007) 193-207
25. Lee N., Xia P., Fischbein N.J., et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57 (2003) 49-60
26. Eisbruch A., Foote R.L., O'Sullivan B., et al. Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12 (2002) 238-249
27. Eisbruch A. Intensity-modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2 (2005) 34-39
28. Som P.M. The present controversy over the imaging method of choice for evaluating the soft tissues of the neck. AJNR Am J Neuroradiol 18 (1997) 1869-1872
29. Delbeke D., and Martin W.H. Positron emission tomography imaging in oncology. Radiol Clin North Am 39 (2001) 883-917
30. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
31. Salama J.K., Stenson K.M., Kistner E.O., et al. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol 19 (2008) 1787-1794
32. Gregoire V., and Maingon P. Intensity modulated radiation therapy in head and neck squamous cell carcinoma: State of the art and future challenges. Cancer Radiother 9 (2005) 42-50
33. Harari P.M. Promising new advances in head and neck radiotherapy. Ann Oncol 16 Suppl. 6 (2005) vi13-vi19
34. Burnet N.G., Thomas S.J., Burton K.E., et al. Defining the tumour and target volumes for radiotherapy. Cancer Imaging 4 (2004) 153-161
35. Lee N., Puri D.R., Blanco A.I., et al. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck 29 (2007) 387-400
36. Mendenhall W.M., Amdur R.J., and Palta J.R. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 24 (2006) 2618-2623
37. Caglar H.B., and Allen A.M. Intensity-modulated radiotherapy for head and neck cancer. Clin Adv Hematol Oncol 5 (2007) 425-431
38. Hunt M.A., Zelefsky M.J., Wolden S., et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 49 (2001) 623-632
39. Wolden S.L., Zelefsky M.J., Hunt M.A., et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 49 (2001) 1229-1234
40. Xia P., Fu K.K., Wong G.W., et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 (2000) 329-337
41. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
42. Kwong D.L., Pow E.H., Sham J.S., et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer 101 (2004) 1584-1593
43. Wolden S.L., Chen W.C., Pfister D.G., et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
44. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25 (2007) 4873-4879
45. Perez C.A., Devineni V.R., Marcial-Vega V., et al. Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 23 (1992) 271-280
46. Sanguineti G., Geara F.B., Garden A.S., et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control. Int J Radiat Oncol Biol Phys 37 (1997) 985-996
47. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48 (2000) 711-722
48. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
49. Eisbruch A., Ship J.A., Dawson L.A., et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27 (2003) 832-837
50. Garden A.S., Morrison W., Rosenthal D., et al. Intensity modulated radiation therapy (IMRT) for metastatic cervical adenopathy from oropharynx carcinoma. Int J Radiat Oncol Biol Phys 57 (2003) S302
51. Hall E.J., and Wuu C.S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
52. Huang K., Lee N., and Xia P. Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: A single institutional experience. Int J Radiat Oncol Biol Phys 57 (2003) S302
53. Yao M., Nguyen T., Buatti J.M., et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 29 (2006) 606-612